This big Warriors backer now is shooting for biotech

The head of one of the world's largest ecommerce conglomerates — whose company is a major partner of the Golden State Warriors — is charging into biotech with an investment in a late-stage cancer drug development company.

Billionaire Hiroshi "Mickey" Mikitani, who placed a major center for Japan's Rakuten Inc. in San Mateo, headlined a $284 million Series C financing for San Diego's Rakuten Aspyrian and plans to move most of the company's 100 jobs to San Mateo, where it now has 10 employees.


Previous Bay Area bank makes key hire to debut venture lending
Next Inova's future plans for Merrifield campus shrink significantly

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *